CVSA Earnings Date: Feb 2, 2027 (Estimated) — Covista Inc.
NYSE
Updated
When is CVSA's next earnings date?
Covista Inc. (CVSA) is expected to report Q2 2027 earnings on Tuesday, February 2, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $2.39 on revenue of $520.6M.
How did CVSA do in its last earnings report?
In its most recent report on Oct 29, 2026 (Q1 2027), Covista Inc. posted EPS of $2.19 versus the $1.83 estimate, a beat of 19.7%. Revenue was $511.5M against a $491.1M estimate.
How much does CVSA stock move after earnings?
CVSA beat EPS estimates in 3 of its last 3 reported quarters. Over the last 2 reports the stock moved an average of 13.9% (up or down) in the day after earnings.
About Covista Inc.
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.
🤖 AI Earnings Analysis
Covista delivered a strong Q1 beat, with revenue up 927.1% to $512M and EPS of $2.19 versus $1.83 expected; extraordinary growth warrants scrutiny for comparability. Management guided to $2.0B–$2.1B revenue and $8.90–$9.15 EPS.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-29 | Q1 2027 | 1.83 | 2.19 | +19.67% | $511.5M | ✅ Beat | — | — | — |
| 2026-08-06 | Q4 2026 | 1.89 | 2.09 | +10.58% | $501.4M | ✅ Beat | +13.46% | +6.14% | +3.08% |
| 2026-05-07 | Q3 2026 | 1.72 | 1.98 | +15.12% | $487.0M | ✅ Beat | +14.30% | +8.13% | +7.97% |
| 2022-12-31 | — | 0.54 | — | $362.8M | — | — | — | — | |
| 2022-09-30 | — | 0.09 | — | $354.3M | — | — | — | — | |
| 2022-06-30 | — | 0.16 | — | $360.6M | — | — | — | — | |
| 2022-03-31 | — | -2.54 | — | $364.3M | — | — | — | — | |
| 2021-12-31 | — | 0.36 | — | $371.2M | — | — | — | — |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q1 FY27 · $511.5M total
| Segment | Share | Revenue | YoY |
|---|---|---|---|
| Walden University | 42.4% | $216.7M | — |
| Chamberlain | 37.6% | $192.4M | — |
| Medical and Veterinary | 20.0% | $102.5M | — |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.